Navigation Links
Atrial in Medical News

MULTAQ(R) (dronedarone) for Atrial Fibrillation or Atrial Flutter Now Available in the United States

BRIDGEWATER, N.J., July 28 /PRNewswire-FirstCall/ -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY ) announced today that MULTAQ((R)) (dronedarone) 400 mg Tablets is now available in pharmacies in the United States. MULTAQ is an anti-arrhythmic drug indicated to reduce the risk of c...

CardioFocus Receives CE Mark for Atrial Fibrillation Ablation Catheter

MARLBOROUGH, Mass., July 7 /PRNewswire/ -- CardioFocus, Inc. ( www.cardiofocus.com ) announced today that it has received a CE Mark allowing the company to commence European marketing of the Endoscopic Ablation System (EAS) to treat patients with atrial fibrillation. The EAS is the latest gener...

FDA Approves Multaq(R) for Patients with Atrial Fibrillation or Atrial Flutter

PARIS, July 2 /PRNewswire-FirstCall/ -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY ) announced today that the U.S. Food and Drug Administration (FDA) has approved Multaq(R) (dronedarone) 400 mg Tablets. Patients with atrial fibrillation (AF) or atrial flutter (AFL) soon will have a new treatm...

Frost & Sullivan: Momentum Mounting for Catheter Ablation Technologies in Treatment of Atrial Fibrillation

Clinical Specialists Provide Feedback on Current and Future Trends MOUNTAIN VIEW, Calif., June 8 /PRNewswire/ -- A recent Frost & Sullivan end-user survey shows increased awareness and utilization of new tools and approaches to treating atrial fibrillation (Afib). Of the various forms of...

Health and Advocacy Leaders Mobilize to Bring Attention to Atrial Fibrillation, a Costly and Misunderstood Cardiovascular Disease

Survey Shows Patient and Healthcare Professionals are 'Out of Sync' About Potential Serious Health Consequences WASHINGTON, May 18 /PRNewswire-USNewswire/ -- As the nation's 76 million Baby Boomers approach their Medicare years, a diverse group of healthcare leaders today joined together ...

eCardio Launches NEW Atrial Fibrillation Information System (AFIS(TM))

First Comprehensive Software Application to Offer Single Platform for AF Patient Management BOSTON, May 15 /PRNewswire/ -- eCardio Diagnostics ( www.ecardio.com ) announced the launch of its NEW Atrial Fibrillation Information System (AFIS(TM)) today at Heart Rhythm 2009, the Annual Scient...

More>>

Atrial in Medical Technology

deCODE Discovers Second Common Genetic Risk Factor for Atrial Fibrillation and Stroke

REYKJAVIK, Iceland, July 13 /PRNewswire-FirstCall/ -- Scientists at deCODE genetics (Nasdaq: DCGN ) and colleagues from Europe and the United States today report the discovery of a common single-letter variant in the sequence of the human genome (SNP) conferring increased risk of atrial fibr...

New AHRQ Study Finds Mixed Evidence on Use of Radiofrequency Catheter Ablation for Treating Atrial Fibrillation

ROCKVILLE, Md., July 6 /PRNewswire-USNewswire/ -- A procedure that sends targeted energy into the heart through a catheter can be used to treat a common type of irregular heartbeat, but little is known about the treatment's long-term benefits and the best methods and circumstances for applying it,...

New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation

- Multaq(R) (dronedarone) significantly reduced the risk of cardiovascular hospitalization or death by 24 percent in patients with atrial fibrillation - PARIS, Feb. 11 /PRNewswire-FirstCall/ -- Sanofi-aventis (Paris Bourse: EURONEXT: SAN; and New York: NYSE: SNY ) announced today that the...

New Phase II Data Show Safety of Once-Daily Oral Factor Xa Inhibitor, DU-176b, Comparable to Warfarin in Patients With Non-Valvular Atrial Fibrillation

SAN FRANCISCO, Dec. 7 /PRNewswire-FirstCall/ -- Patients with non-valvular atrial fibrillation receiving either 30 mg or 60 mg once-daily dose of DU-176b, an investigational oral Factor Xa inhibitor, experienced comparable safety and tolerability compared to those taking warfarin, according to new...

Daiichi Sankyo Initiates Phase III Trial of Its Investigational Factor Xa Inhibitor, DU-176b, in Patients With Atrial Fibrillation

TOKYO and EDISON, N.J., Dec. 7 /PRNewswire-FirstCall/ -- Daiichi Sankyo Company, Limited (TSE: 4568), announced today that it has initiated its pivotal Phase III trial for DU-176b, an investigational oral Factor Xa inhibitor, in patients with atrial fibrillation. DU-176b is being developed solely...

Dronedarone (Multaq(R)) Reduced the Incidence and Duration of Hospitalization in Patients with Atrial Fibrillation

New post-hoc analysis from ATHENA Study showed that Multaq(R) on top of standard therapy significantly decreased the total number of hospital days by 28% in patients with atrial fibrillation or flutter NEW ORLEANS, Nov. 11 /PRNewswire-FirstCall/ -- New data from the landmark ATHENA trial sho...
Atrial in Medical Products

CARDIA Atrial Septal Defect Closure Device

Description: The CARDIA ASD Occluder has been developed for the transvenous closure of atrial septal defects. Introduced through transseptal venous sheaths the device offers a safe and reliable method for the percutaneous closure of ASD's with a super low profile. A self centering mechanism is incorporated...
Company:CARDIA, Inc.

Streamline Temporary Pacing Leads Atrial 6492 Unipolar Temporary Atrial Pacing Lead

Description: Medtronic presents the Streamline family of temporary sensing and pacing leads. Our engineers have taken the gold standard in temporary pacing leads and improved upon the features that make them easy to use and less traumatic to heart tissue. The Streamline Temporary Pacing Leads are designe...
Company:Medtronic Inc.

Selute® Picotip Atrial J

Description: Steroid eluting pacemaker leads with preformed J...
Company:Guidant Corporation

Fineline II Sterox Atrial J Model 4480

Description: The Guidant Fineline II Sterox Atrial J is a steroid-eluting pacing lead designed for permanent implantation for either atrial or ventricular applications....
Company:Guidant Corporation

Fineline II Sterox Atrial J Model 4479

Description: The Guidant Fineline II Sterox Atrial J is a steroid-eluting pacing lead designed for permanent implantation for either atrial or ventricular applications....
Company:Guidant Corporation

Selute Picotip Atrial J

Description: Selute Picotip Atrial-J steroid eluting passive fixation lead...
Company:Guidant Corporation

More>>

Atrial in Medical Definition

Pathology

...diac arrest - Tachycardia ( Supraventricular tachycardia , AV nodal reentrant tachycardia , Ventricular tachycardia ) - Premature contraction ( atrial , Ventricular ) - Sick sinus syndrome Other heart conditions Heart failure - Cardiomegaly - Ventricular hypertrophy ( Left , Right )...

Numbering aberrant rhythms

...nly aberrant beat that makes use of these adjectives; others are premature atrial contractions , parasystole , and escape complexes . Examples ...ntricular contractions = Normal, PVC, Normal, PVC... Trigeminal premature atrial contractions = Normal, Normal, PAC, Normal, Normal, PAC... Quadrageminal ...

Proteopathy

... Crystallins Medullary thyroid carcinoma Calcitonin Cardiac atrial amyloidosis atrial natriuretic factor Pituitary prolactinoma Prolactin Hereditar...
Atrial in Medical Dictionary

Tachycardia

...artbeat that's too fast. ... Watch an animation of atrial tachycardia . Sinus tachycardia is a heart ra...s normal response to anxiety, fever, rapid ... atrial tachycardia or atrial fibrillation happens when electrical signals in t...

Sleep apnea

... prognosis. Likewise, whether treating obstructive sleep apnea decreases the incidence of ... Sleep apnea is more common in people with atrial fibrillation (irregular ... InteliHealth - Featuring Harvard Medical School's consumer health information. ... Obstructive sleep apnea also a...

Septum

...ge of the sinuses, ... Detailed information on atrial septal defect, including causes, symptoms, ... A small opening in the atrial septum allows a small amount of blood to pass ...the septum piercing goes. ... Defects in the atrial septum are traditionally divided into four types...

Patent foramen ovale

... 3.1.2 Patent foramen ovale . 3.2 Ostium primum atrial septal defect ... A patent foramen ovale (PFO) is a small chan...- Diagnosis methods - Treatment options ... Patent Foramen Ovale . atrial Septal Defect. Ventricular Septal Defect. FDA Disclaimer ... A patent fo...

Palpitations

...Treatment Alternative treatment Prognosis Prevention Resources Palpitations Definition A Read about palpitations , types, including premature atrial contractions, ... Palpitations occur when a person can feel abnormalities in the normal beating of ... List of 489 disease causes of Palpitat...

Oliguria

...ia (excretion of less than 400 ml of urine per day) is often the ... atrial Fibrillation medical glossary includes a list of atrial ... (cyanotic) skin, decreased urine flow ( oliguria ), and mental change...
Atrial in Biological News

Enzyme doesn't act alone in atrial fibrillation

HOUSTON (June 17, 2009) An overactive enzyme is behind a leaky calcium channel that plays a role in the development of atrial fibrillation, which is the most common cardiac arrhythmia that is responsible for a third of all strokes. However, it doesn't act alone, say researchers at Baylor College...

Mitochondrial dysfunction and redox signaling in atrial tachyarrhythmia

Researchers at the University Hospital of Magdeburg (Germany) have discovered that atrial tachycardia is associated with mitochondrial dysfunction and oxidative stress followed by the activation of the NF-kB signalling pathway with induction of NF-kB target gene expression in atrial tissue. Their ...

Surgeons develop simpler way to cure atrial fibrillation

Physicians have an effective new option for treating atrial fibrillation, a common irregular heart rhythm that can cause stroke. Heart surgeons at Washington University School of Medicine in St. Louis have developed and tested a device that radically shortens and simplifies a complex surgical proce...

Targeted drug therapy prevents exercise-induced arrhythmias

...e model to study medications and interventions for the disorder. They tried flecainide, a clinically available anti-arrhythmic that is used to treat atrial fibrillation. It worked. In isolated heart cells, flecainide blocked the ryanodine receptor and the calcium "leak" (the underlying molecular defect ...

Common gene variants increase risk of hypertension, may lead to new therapies

... To search for hypertension-associated variants, the investigators focused on two genes called NPPA and NPPB that are involved in the production of atrial and B-type natriuretic peptides (ANP and BNP) proteins known to relax blood vessels and to be involved in the excretion of dietary sodium. Animals in...

Genetic testing not cost-effective in guiding initial dosing of common blood thinner

... blood-thinner warfarin may not be cost-effective for typical patients with atrial fibrillation but may be for patients at higher risk for major bleeding. ...mmonly prescribed to prevent blood clotting, particularly for patients with atrial fibrillationa type of abnormal heart rhythm. Mark Eckman, MD, professor ...
Atrial in Biological Technology

deCODE Study Expands Clinical Utility of deCODE AF(TM) for Improving the Diagnosis of Atrial Fibrillation and Preventing Stroke

REYKJAVIK, Iceland, November 10 /PRNewswire-FirstCall/ -- In a presentation yesterday at the American Heart Association Scientific Sessions 2008, scientists from deCODE genetics (Nasdaq: DCGN ) presented data from large scale case-control studies in multiple populations that underscore the cli...

FDA Approves Ranexa(R) for First Line Anti Anginal Use and Adds New Claims for Reduction of Ventricular Arrhythmias, Bradycardia, New Atrial Fibrillation and HbA1c

- New labeling reinforces strong safety profile of Ranexa - - Conference call scheduled for 8:00 a.m. ET/5:00 a.m. PT - PALO ALTO, Calif., Nov. 6 /PRNewswire-FirstCall/ -- CV Therapeutics, Inc. (Nasdaq: CVTX ) announced today that the U.S. Food and Drug Administration (FDA) has approved a ...

Portola Pharmaceuticals Initiates Phase II Trial of Betrixaban, its Novel Oral Factor Xa Inhibitor for Stroke Prevention in Atrial Fibrillation

SOUTH SAN FRANCISCO, Calif., Nov. 3 /PRNewswire/ -- Portola Pharmaceuticals, a biopharmaceutical company developing innovative drugs that provide significant advances in cardiovascular and inflammatory diseases, and cancer, today announced that it has begun patient enrollment in a large Phase ...

Electrophysiology Procedures for Atrial Fibrillation Treatment to Grow Over 25% Annually Over the Next Five Years

Growth will be driven by an increasing physician acceptance of electrophysiology ablation as an effective treatment for atrial fibrillation, according to Millennium Research Group WALTHAM, Mass., March 20 /PRNewswire/ -- According to Millennium Research Group's Global Markets ...

AtriCure Announces Initiation of the ABLATE Pivotal Trial to Evaluate the Isolator Synergy(TM) Bipolar Ablation System to Treat Atrial Fibrillation

WEST CHESTER, Ohio, Feb. 11 /PRNewswire-FirstCall/ -- AtriCure, Inc. (Nasdaq: ATRC ), a medical device company and a leader in cardiac surgical ablation products, today announced that the first patient was successfully treated in AtriCure's ABLATE clinical trial. Dr. Richard Kaplon, a well-kn...

CryoCor to Highlight Products at 13th Annual International Boston Atrial Fibrillation Symposium

Company to also Present at Stanford Group 13th Annual Healthcare Conference SAN DIEGO, Jan. 15 /PRNewswire-FirstCall/ -- CryoCor, Inc. (Nasdaq: CRYO), a medical device company focused on the treatment of cardiac arrhythmias, announced today that it will showcase its Cardiac Cryoablation System a...
Atrial in Biological Dictionary

Transposition

... transposition of the great arteries, children will benefit from ... Those with complete transposition of the great arteries have often had an atrial ... Congenitally corrected transposition : Atrioventricular discordance and ... 1) Omental Transposition . 2) Omental Transplantation ... Transp...

Syncytium

...many other academic journal articles, magazine articles & newspaper archives. Syncytium . ... syncytium . Noun ... Syncytium (n. ... The atrial syncytium is a network of cardiac muscle cells connected by gap ... In sum, cardiac muscle is a syncytium , meaning when one cell contracts...

Sinus venosus

...venarum, also known as the... A Sinus venosus atrial septal defect is a type of atrial septal defect primarily associated with the sinus...... 2 described the pathology of sinus venosus atrial defect(SVD), the anatomical ... ... dictionary ...

Right atrium

.... Right Pulmonary Artery-to-Left Atrium Communication. A Rare Cause of Systemic ... Therefore, the right atrium was opened and, through the atrial septal defect, ... right ventricle, right atrium , inferior third of interventricular septum ... opening into right atrium is guarded by a...

Pulmonary veins

...rnal of Medicine -- Circumferential Pulmonary - Vein Ablation for Chronic atrial Fibrillation ... Angioplasty for Acquired Pulmonary Vein Stenosis After Radiofrequency ... Ablation of Pulmonary Veins Triggering atrial Fibrillation: 5-Year Experience. ... Online Medical Dictionary and gloss...

Pulmonary vein

...ry arteries. ... Pulmonary Vein Isolation Offers Potential Cure for atrial Fibrillation (AF) ... The pulmonary vein region in the left atrium is...rnal of Medicine -- Circumferential Pulmonary - Vein Ablation for Chronic atrial Fibrillation A case is reported in which pulmonary vein stenosis ......
Other Tags
(Date:7/27/2014)... University scientists have shown that a powerful drug given ... only halves the early risk of rejection, but that ... drugs to be used after the operation. , The ... and presented at the World Transplant Congress in San ... difficult transplant conundrum: the powerful combinations of treatments used ...
(Date:7/27/2014)... July 27, 2014 According to a ... Devices Market (Endoscopes, Endoscopic Operative Devices, and Visualization Systems) ... Forecast, 2013-2019" the global endoscopy devices market was valued ... to grow at a CAGR of 6.8% from 2013 ... 36.9 billion in 2019. , Endoscopy procedures are performed ...
(Date:7/27/2014)... constant expansion of companies across the globe has led ... factors that have increased this demand include the application ... learning and development, security and safety, and knowledge sharing ... video market value has crossed $11.21 billion in 2013 ... with a compound annual growth rate (CAGR) of 25.97%. ...
(Date:7/27/2014)... July 27, 2014 The North American ... estimated at $1570 million in 2014, and it is ... CAGR of 4.64%. The report incorporates the factors that ... expectations of growth rates and projected total expenditure. The ... the global markets. Apart from the general overview of ...
(Date:7/27/2014)... (Sunday July 27 11:45 am ET): A ... the surgical sitehas been reduced by 77 percent ... the American College of Surgeons National Surgical Quality ... case study presented at the 2014 ACS NSQIP ... Columbia, reportedly reduced its rate of cardiac surgical ...
Breaking Medicine News(10 mins):Health News:Kidney transplant drug halves the early risk of rejection and allows less toxic treatment 2Health News:Kidney transplant drug halves the early risk of rejection and allows less toxic treatment 3Health News:Global Endoscopy Devices Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 2Health News:Global Endoscopy Devices Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 3Health News:Global Endoscopy Devices Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 4Health News:North America Enterprise Video Market is Expected to Reach $13.00 billion in 2018 - New Report by MicroMarket Monitor 2Health News:North America Enterprise Video Market is Expected to Reach $13.00 billion in 2018 - New Report by MicroMarket Monitor 3Health News:North America Enterprise Video Market is Expected to Reach $13.00 billion in 2018 - New Report by MicroMarket Monitor 4Health News:North America Security and Surveillance Radar Market is Expected to Reach $2030 million in 2019 - New Report by MicroMarket Monitor 2Health News:North America Security and Surveillance Radar Market is Expected to Reach $2030 million in 2019 - New Report by MicroMarket Monitor 3Health News:North America Security and Surveillance Radar Market is Expected to Reach $2030 million in 2019 - New Report by MicroMarket Monitor 4Health News:North America Security and Surveillance Radar Market is Expected to Reach $2030 million in 2019 - New Report by MicroMarket Monitor 5Health News:Surgical safety program greatly reduces surgical site infections for heart operations 2Health News:Surgical safety program greatly reduces surgical site infections for heart operations 3Health News:Surgical safety program greatly reduces surgical site infections for heart operations 4
(Date:7/25/2014)... scientists from 25 countries and 35 states will ... the Genetics Society of America (GSA) next week ... conference will feature close to 500 presentations (including ... including gene expression and regulation, functional genomics, chemical ... and a variety of diseases. , Of ...
(Date:7/25/2014)... at the University of Adelaide has opened the way for ... powdery mildew. , In Australia, annual barley production is second ... mildew is one of the most important diseases of barley. ... discovered the composition of special growths on the cell walls ... into the leaf. , The research, by the ARC Centre ...
(Date:7/25/2014)... After development of diffusion tensor tractography (DTT), which ... reconstruction and estimation for three motor tracts, such ... the corticoreticular pathway became possible. The corticospinal tract ... for motor function in the human brain. Several ... tract by transtentorial herniation. In addition, some studies ...
Breaking Biology News(10 mins):Yeast meeting to showcase latest breakthroughs in genetics and molecular biology 2New hope for powdery mildew resistant barley 2
Other Contents